1. Repository of OAI
Ελληνικά   English  

Browsing by Author Filippatos, T. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 21 to 40 of 59 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effects of hormonal treatment on lipids in patients with cancerFilippatos, T. D.; Liberopoulos, E. N.; Pavlidis, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
The Effects of Hypolipidemic Regimen on Low Density Lipoprotein (Ldl) Phenotype in Patients with Mixed HyperlipidemiaAgouridis, A. P.; Filippatos, T. D.; Moutzouri, E. O.; Kei, A. A.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed HyperlipidemiaAgouridis, A. P.; Kazakou, P. S.; Filippatos, T. D.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitisKiortsis, D. N.; Mavridis, A. K.; Filippatos, T. D.; Vasakos, S.; Nikas, S. N.; Drosos, A. A.24-Nov-2015-
Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli studyFilippatos, T. D.; Kiortsis, D. N.; Gazi, I.; Liberopoulos, E. N.; Georgoula, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeFilippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The effects of orlistat on metabolic parameters and other cardiovascular risk factorsKiortsis, D. N.; Filippatos, T. D.; Elisaf, M. S.24-Nov-2015-
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Dimitriou, A. A.; Tellis, C. C.; Elisaf, M. S.; Mikhailidis, D. P.; Tselepis, A. D.24-Nov-2015-
Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised studyKiortsis, D. N.; Tsouli, S.; Filippatos, T. D.; Konitsiotis, S.; Elisaf, M. S.24-Nov-2015-
Effects of sibutramine plus verapamil SR/trandolapril combination on blood pressure and metabolic parameters in obese patients with mild hypertensionFilippatos, T. D.; Nakou, E.; Liberopoulos, E. N.; Derdemezis, C. S.; Georgoula, M.; Tselepis, A. D.; Elisaf, M. S.; Kiortsis, D. N.24-Nov-2015-
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsNakou, E.; Filippatos, T. D.; Liberopoulos, E. N.; Tselepis, A. D.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisar, M. S.24-Nov-2015-
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsNakou, E.; Filippatos, T. D.; Liberopoulos, E. N.; Tselepis, A. D.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The effects of weight loss on Lp-PLA2 activity and low density lipoprotein (LDL) phenotype in obese womenFilippatos, T. D.; Tzotzas, T.; Kiortsis, D. N.; Triantos, A.; Karamouzis, M.; Tselepis, A.24-Nov-2015-
Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Filippatos, T. D.; Derdemezis, C. S.; Kalantzi, K. J.; Goudevenos, J.; Seferiadis, K.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemiaFilippatos, T. D.; Elisaf, M. S.24-Nov-2015-
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype definitions and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Kostapanos, M. S.; Saougos, V. G.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolGazi, I. F.; Filippatos, T. D.; Tsimihodimos, V.; Saougos, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Showing results 21 to 40 of 59 < previous   next >